These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21493753)

  • 1. Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism.
    Smith KJ; Murray IA; Tanos R; Tellew J; Boitano AE; Bisson WH; Kolluri SK; Cooke MP; Perdew GH
    J Pharmacol Exp Ther; 2011 Jul; 338(1):318-27. PubMed ID: 21493753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3',4'-dimethoxy-α-naphthoflavone.
    Murray IA; Flaveny CA; Chiaro CR; Sharma AK; Tanos RS; Schroeder JC; Amin SG; Bisson WH; Kolluri SK; Perdew GH
    Mol Pharmacol; 2011 Mar; 79(3):508-19. PubMed ID: 21127131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a selective modulator of aryl hydrocarbon (Ah) receptor activity that exhibits anti-inflammatory properties.
    Murray IA; Krishnegowda G; DiNatale BC; Flaveny C; Chiaro C; Lin JM; Sharma AK; Amin S; Perdew GH
    Chem Res Toxicol; 2010 May; 23(5):955-66. PubMed ID: 20423157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for ligand-mediated selective modulation of aryl hydrocarbon receptor activity.
    Murray IA; Morales JL; Flaveny CA; Dinatale BC; Chiaro C; Gowdahalli K; Amin S; Perdew GH
    Mol Pharmacol; 2010 Feb; 77(2):247-54. PubMed ID: 19903824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of Th17 and T regulatory cell differentiation by aryl hydrocarbon receptor dependent xenobiotic response element dependent and independent pathways.
    Mohinta S; Kannan AK; Gowda K; Amin SG; Perdew GH; August A
    Toxicol Sci; 2015 Jun; 145(2):233-43. PubMed ID: 25716673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of aryl hydrocarbon receptor signaling by 6,2',4'-trimethoxyflavone.
    Murray IA; Flaveny CA; DiNatale BC; Chairo CR; Schroeder JC; Kusnadi A; Perdew GH
    J Pharmacol Exp Ther; 2010 Jan; 332(1):135-44. PubMed ID: 19828881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavone antagonists bind competitively with 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) to the aryl hydrocarbon receptor but inhibit nuclear uptake and transformation.
    Henry EC; Kende AS; Rucci G; Totleben MJ; Willey JJ; Dertinger SD; Pollenz RS; Jones JP; Gasiewicz TA
    Mol Pharmacol; 1999 Apr; 55(4):716-25. PubMed ID: 10101030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Structural Switch between Agonist and Antagonist Bound Conformations for a Ligand-Optimized Model of the Human Aryl Hydrocarbon Receptor Ligand Binding Domain.
    Perkins A; Phillips JL; Kerkvliet NI; Tanguay RL; Perdew GH; Kolluri SK; Bisson WH
    Biology (Basel); 2014 Oct; 3(4):645-69. PubMed ID: 25329374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aryl hydrocarbon receptor regulates the cholesterol biosynthetic pathway in a dioxin response element-independent manner.
    Tanos R; Patel RD; Murray IA; Smith PB; Patterson AD; Perdew GH
    Hepatology; 2012 Jun; 55(6):1994-2004. PubMed ID: 22234961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and pharmacological analysis identifies a physiological role for the AHR in epidermal differentiation.
    van den Bogaard EH; Podolsky MA; Smits JP; Cui X; John C; Gowda K; Desai D; Amin SG; Schalkwijk J; Perdew GH; Glick AB
    J Invest Dermatol; 2015 May; 135(5):1320-1328. PubMed ID: 25602157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-mediated cytoplasmic retention of the Ah receptor inhibits macrophage-mediated acute inflammatory responses.
    Muku GE; Lahoti TS; Murray IA; Podolsky MA; Smith KJ; Hubbard TD; Kuzu G; Gowda K; Amin SG; Perdew GH
    Lab Invest; 2017 Dec; 97(12):1471-1487. PubMed ID: 28892097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand selectivity and gene regulation by the human aryl hydrocarbon receptor in transgenic mice.
    Flaveny CA; Murray IA; Chiaro CR; Perdew GH
    Mol Pharmacol; 2009 Jun; 75(6):1412-20. PubMed ID: 19299563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl hydrocarbon receptor antagonism mitigates cytokine-mediated inflammatory signalling in primary human fibroblast-like synoviocytes.
    Lahoti TS; John K; Hughes JM; Kusnadi A; Murray IA; Krishnegowda G; Amin S; Perdew GH
    Ann Rheum Dis; 2013 Oct; 72(10):1708-16. PubMed ID: 23349129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of selective activation of aryl hydrocarbon receptor nongenomic calcium signaling by pyrene.
    Brinchmann BC; Le Ferrec E; Bisson WH; Podechard N; Huitfeldt HS; Gallais I; Sergent O; Holme JA; Lagadic-Gossmann D; Øvrevik J
    Biochem Pharmacol; 2018 Dec; 158():1-12. PubMed ID: 30248327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylindoles and Methoxyindoles are Agonists and Antagonists of Human Aryl Hydrocarbon Receptor.
    Stepankova M; Bartonkova I; Jiskrova E; Vrzal R; Mani S; Kortagere S; Dvorak Z
    Mol Pharmacol; 2018 Jun; 93(6):631-644. PubMed ID: 29626056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3'-methoxy-4'-nitroflavone, a reported aryl hydrocarbon receptor antagonist, enhances Cyp1a1 transcription by a dioxin responsive element-dependent mechanism.
    Zhou J; Gasiewicz TA
    Arch Biochem Biophys; 2003 Aug; 416(1):68-80. PubMed ID: 12859983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of ligand-selective binding of the aryl hydrocarbon receptor to putative DNA binding sites regulating expression of Bax and paraoxonase 1 genes.
    DeGroot DE; Hayashi A; Denison MS
    Arch Biochem Biophys; 2014 Jan; 541():13-20. PubMed ID: 24200861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential endogenous ligand for the aryl hydrocarbon receptor has potent agonist activity in vitro and in vivo.
    Henry EC; Bemis JC; Henry O; Kende AS; Gasiewicz TA
    Arch Biochem Biophys; 2006 Jun; 450(1):67-77. PubMed ID: 16545771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aryl Hydrocarbon Receptor (AHR) Ligands as Selective AHR Modulators (SAhRMs).
    Safe S; Jin UH; Park H; Chapkin RS; Jayaraman A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of novel CH223191-based antagonists of the aryl hydrocarbon receptor.
    Choi EY; Lee H; Dingle RW; Kim KB; Swanson HI
    Mol Pharmacol; 2012 Jan; 81(1):3-11. PubMed ID: 21967751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.